Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor.
about
Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell culturesFuture technology insight: mass spectrometry imaging as a tool in drug research and development.Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Spatial Quantitation of Drugs in tissues using Liquid Extraction Surface Analysis Mass Spectrometry ImagingAbsolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues.MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discoveryMALDI Mass Spectrometry Imaging for Visualizing In Situ Metabolism of Endogenous Metabolites and Dietary PhytochemicalsCurrent status and future perspectives of mass spectrometry imaging.MALDI Imaging Mass Spectrometry-A Mini Review of Methods and Recent DevelopmentsMatrix effects in biological mass spectrometry imaging: identification and compensation.Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay.Lipid imaging by mass spectrometry - a review.Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS.Current frontiers in clinical research application of MALDI imaging mass spectrometry.DMSO-enhanced MALDI MS imaging with normalization against a deuterated standard for relative quantification of dasatinib in serial mouse pharmacology studies.A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry.MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.New insights into the structural and spatial variability of cell-wall polysaccharides during wheat grain development, as revealed through MALDI mass spectrometry imaging.Using a single, high mass resolution mass spectrometry platform to investigate ion suppression effects observed during tissue imaging.Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standardsIn situ drug and metabolite analysis [corrected] in biological and clinical research by MALDI MS imaging.Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionizationA spiked tissue-based approach for quantification of phosphatidylcholines in brain section by MALDI mass spectrometry imaging.XMS: cross-platform normalization method for multimodal mass spectrometric tissue profiling.Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging.Quantification in MALDI-MS imaging: what can we learn from MALDI-selected reaction monitoring and what can we expect for imaging?Influence of Desorption Conditions on Analyte Sensitivity and Internal Energy in Discrete Tissue or Whole Body Imaging by IR-MALDESIAssessing drug and metabolite detection in liver tissue by UV-MALDI and IR-MALDESI mass spectrometry imaging coupled to FT-ICR MS.Drug localizations in tissue by mass spectrometry imaging.Quantitative profiling of tissue drug distribution by MS imaging.Future directions of imaging MS in pharmaceutical R&D.An introduction to MS imaging in drug discovery and development.Novel insights in drug metabolism by MS imaging.Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imagingProbing the Relationship Between Detected Ion Intensity, Laser Fluence, and Beam Profile in Thin Film and Tissue in MALDI MSI.Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot.Extraction efficiency and implications for absolute quantitation of propranolol in mouse brain, liver and kidney tissue sections using droplet-based liquid microjunction surface sampling high-performance liquid chromatography/electrospray ionizationProgress and Potential of Imaging Mass Spectrometry Applied to Biomarker Discovery.Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity Studies.Liquid chromatography-matrix-assisted laser desorption/ionization mass spectrometric imaging with sprayed matrix for improved sensitivity, reproducibility and quantitation
P2860
Q26820859-90F47B97-6425-40E6-B21F-63520598DED3Q28087460-A508487B-353B-46A4-AFBC-CE9389C0A31EQ28396816-3A3B2902-F4A4-4ED2-990C-6BA890DC251AQ28818959-296EA575-3A93-4047-A06D-7833CC795479Q30371747-AD964959-C092-4DA6-B6F2-E0AA936022AFQ30406018-D472F608-2E20-4563-893C-5194E34C318BQ30434703-A446249D-2363-4303-A6C2-4225DE34B7D8Q30452337-1A7D1C66-A90D-4FA6-A420-17C5D486EE78Q31146394-1743779E-5646-4062-BCCC-EA5155CC08C4Q33835517-62CA9074-FE0D-4580-A9EA-7C78891E28D9Q34364249-556725A0-0A00-4E15-9CAE-66D78110ABCFQ34546576-263E7FE2-086B-4C35-983F-D2FE1FBDFF5DQ34593213-9D7B1D92-37CB-434F-BCD3-5EC97430EE80Q34777079-501884A3-AB71-4A86-9C23-04E4DE96A2E9Q35016405-62FC33B2-B195-4A41-87B2-1B85D1072719Q35054662-C5A571A6-CCBF-4A81-980D-A318246AC034Q35069025-11042027-CE72-4B32-9BF4-FDC30155ED9DQ35112191-B9C3108D-1571-4823-81F3-D2CCD37BE212Q35134075-90C93662-9450-4776-96EC-544FE4179376Q35149911-24615B3F-CCE5-4DB4-985C-073B81BD84C1Q35191571-AE1EB448-EE7B-4421-80A3-32CF617B6B8FQ35334381-F05A990D-89C5-4DDA-B1A4-68E40987C825Q35345555-66695B2C-C027-4802-A82C-ADD8E59C46E0Q35404471-EB76878F-B93C-4749-BBD5-00E2C373D279Q35449912-1501365D-5029-4F49-AD22-27ACC7866A53Q35500606-21069D27-C767-4E61-AC67-039D3DD592BAQ35587548-8B44A841-32D4-4514-9294-A0765320AE5DQ35657674-0A1F8309-5E2A-4715-85CD-282A41CD38D1Q35761343-2FC3B97D-4C6A-4FCF-BC6E-FFAD3327A2F5Q35818508-5878AD49-5E7C-4BC7-9FB1-B996AD73604FQ35824946-2F5EA823-5AE3-4711-8DA3-3BDFA6256D2CQ35825043-953739EA-E7BF-4B77-A349-CFD2A1EFF625Q35936145-6F7CFD48-E6EE-4F9B-8853-94101C22D179Q35973401-FE7AB502-33C1-4E5B-A9B9-AE25A06B9004Q36024404-58423700-837E-4251-B4C8-5B2311470710Q36140124-C9B0145B-3587-403F-AD49-8BD951768DB5Q36317887-2907A4E4-536E-4874-A468-8DC8B2A9AB8FQ36372802-7123593E-C262-48C1-B41F-F12F18C10480Q36412738-F44528B6-8283-4188-9DD7-933CF20E7944Q37340446-19B3A7C3-6342-40E4-A9A8-513BD4CF6083
P2860
Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Quantitative mass spectrometry ...... ation as normalization factor.
@ast
Quantitative mass spectrometry ...... ation as normalization factor.
@en
Quantitative mass spectrometry ...... ation as normalization factor.
@nl
type
label
Quantitative mass spectrometry ...... ation as normalization factor.
@ast
Quantitative mass spectrometry ...... ation as normalization factor.
@en
Quantitative mass spectrometry ...... ation as normalization factor.
@nl
prefLabel
Quantitative mass spectrometry ...... ation as normalization factor.
@ast
Quantitative mass spectrometry ...... ation as normalization factor.
@en
Quantitative mass spectrometry ...... ation as normalization factor.
@nl
P2093
P1476
Quantitative mass spectrometry ...... ation as normalization factor.
@en
P2093
David Bonnel
Fabien Pamelard
François Bouzom
Gregory Hamm
Jean-Marie Delbos
Jonathan Stauber
Raphael Legouffe
P304
P356
10.1016/J.JPROT.2012.07.035
P577
2012-07-26T00:00:00Z